Evidence map›Paper›PMID 28955890›Full record

ArticleBiochemistry and biophysics reports2016

Establishment of combined analytical method to extract the genes of interest from transcriptome data.

Akinori Ishihara, Hidenori Yamanaka, Reiko Takahashi, Tomomi Numajiri, Saki Kaneko, Yoko Ishizawa, Sakuji Koya, Kiyoshi Yamauchi

Open access · goldAbstract read
In one paragraph

Article in Biochemistry and biophysics reports, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 97% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 0 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Akinori IshiharaDepartment of Biological Science, Faculty of Science, Shizuoka University, 836 Ohya, Shizuoka 422-8529, Japan.
Hidenori YamanakaChemicals Assessment Center, Chemicals Evaluation and Research Institute, 1600, Shimo-Takano, Sugitomachi, Kitakatsushika-gun, Saitama 345-0043, Japan.
Reiko TakahashiWakanyaku Medical Institute, Ltd., 1193 Fujimimachi Akagiyama, Maebashi 371-0101, Japan.
Tomomi NumajiriWakanyaku Medical Institute, Ltd., 1193 Fujimimachi Akagiyama, Maebashi 371-0101, Japan.
Saki KanekoWakanyaku Medical Institute, Ltd., 1193 Fujimimachi Akagiyama, Maebashi 371-0101, Japan.
Yoko IshizawaWakanyaku Medical Institute, Ltd., 1193 Fujimimachi Akagiyama, Maebashi 371-0101, Japan.
Sakuji KoyaWakanyaku Medical Institute, Ltd., 1193 Fujimimachi Akagiyama, Maebashi 371-0101, Japan.
Kiyoshi YamauchiDepartment of Biological Science, Faculty of Science, Shizuoka University, 836 Ohya, Shizuoka 422-8529, Japan.
Shizuoka University · JPChemicals Evaluation and Research Institute · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Techniques for analyzing genome-wide expression profiles, such as the microarray technique and next-generation sequencers, have been developed. While these techniques can provide a lot of information about gene expression, selection of genes of interest is complicated because of excessive gene expression data. Thus, many researchers use statistical methods or fold change as screening tools for finding gene sets whose expression is altered between groups, which may result in the loss of important information. In the present study, we aimed to establish a combined method for selecting genes of interest with a small magnitude of alteration in gene expression by coupling with proteome analysis. We used hypercholesterolemic rats to examine the effects of a crude herbal drug on gene expression and proteome profiles. We could not select genes of interest by using standard methods. However, by coupling with proteome analysis, we found several effects of the crude herbal drug on gene expression. Our results suggest that this method would be useful in selecting gene sets with expressions that do not show a large magnitude of alteration.

Indexed as

Crude drugPathwayProteomeTranscriptome

Identifiers

PMID28955890
PMCPMC5613277
OpenAlexW2401404148

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.